AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Smith
Sidney C
SC
Allen
Jerilyn
J
Blair
Steven N
SN
Bonow
Robert O
RO
Brass
Lawrence M
LM
Fonarow
Gregg C
GC
Grundy
Scott M
SM
Hiratzka
Loren
L
Jones
Daniel
D
Krumholz
Harlan M
HM
Mosca
Lori
L
Pasternak
Richard C
RC
Pearson
Thomas
T
Pfeffer
Marc A
MA
Taubert
Kathryn A
KA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D003327:Coronary Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007252:Influenza Vaccines; D050356:Lipid Metabolism; D012084:Renin-Angiotensin System / Q000502:physiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D007252:Influenza Vaccines